vs
Side-by-side financial comparison of Dominari Holdings Inc. (DOMH) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
Dominari Holdings Inc. is the larger business by last-quarter revenue ($30.1M vs $18.3M, roughly 1.6× ROCKWELL MEDICAL, INC.). ROCKWELL MEDICAL, INC. runs the higher net margin — -3.0% vs -438.1%, a 435.1% gap on every dollar of revenue. On growth, Dominari Holdings Inc. posted the faster year-over-year revenue change (220.4% vs -25.6%). Over the past eight quarters, Dominari Holdings Inc.'s revenue compounded faster (369.1% CAGR vs -10.1%).
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
DOMH vs RMTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $30.1M | $18.3M |
| Net Profit | $-131.8M | $-554.0K |
| Gross Margin | — | 21.1% |
| Operating Margin | -8.9% | -2.2% |
| Net Margin | -438.1% | -3.0% |
| Revenue YoY | 220.4% | -25.6% |
| Net Profit YoY | -12426.2% | 26.7% |
| EPS (diluted) | $-6.94 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $30.1M | $18.3M | ||
| Q3 25 | $50.8M | $15.9M | ||
| Q2 25 | $34.1M | $16.1M | ||
| Q1 25 | $8.1M | $18.9M | ||
| Q4 24 | $9.4M | $24.7M | ||
| Q3 24 | $4.0M | $28.3M | ||
| Q2 24 | $6.2M | $25.8M | ||
| Q1 24 | $1.4M | $22.7M |
| Q4 25 | $-131.8M | $-554.0K | ||
| Q3 25 | $125.2M | $-1.8M | ||
| Q2 25 | $16.6M | $-1.5M | ||
| Q1 25 | $-32.5M | $-1.5M | ||
| Q4 24 | $1.1M | $-756.0K | ||
| Q3 24 | $-4.2M | $1.7M | ||
| Q2 24 | $-6.1M | $343.0K | ||
| Q1 24 | $-5.4M | $-1.7M |
| Q4 25 | — | 21.1% | ||
| Q3 25 | — | 14.3% | ||
| Q2 25 | — | 15.6% | ||
| Q1 25 | — | 16.1% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | — | 22.0% | ||
| Q2 24 | — | 17.6% | ||
| Q1 24 | — | 13.5% |
| Q4 25 | -8.9% | -2.2% | ||
| Q3 25 | -3.1% | -9.9% | ||
| Q2 25 | -57.0% | -8.4% | ||
| Q1 25 | -394.6% | -7.2% | ||
| Q4 24 | 0.4% | -2.1% | ||
| Q3 24 | -79.1% | 6.8% | ||
| Q2 24 | -44.3% | 2.0% | ||
| Q1 24 | -205.2% | -5.8% |
| Q4 25 | -438.1% | -3.0% | ||
| Q3 25 | 246.4% | -11.0% | ||
| Q2 25 | 48.7% | -9.3% | ||
| Q1 25 | -400.5% | -8.0% | ||
| Q4 24 | 11.4% | -3.1% | ||
| Q3 24 | -104.2% | 5.9% | ||
| Q2 24 | -99.1% | 1.3% | ||
| Q1 24 | -398.0% | -7.6% |
| Q4 25 | $-6.94 | $-0.01 | ||
| Q3 25 | $7.27 | $-0.05 | ||
| Q2 25 | $1.12 | $-0.05 | ||
| Q1 25 | $-3.02 | $-0.04 | ||
| Q4 24 | $0.21 | $-0.02 | ||
| Q3 24 | $-0.67 | $0.04 | ||
| Q2 24 | $-1.01 | $0.01 | ||
| Q1 24 | $-0.91 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $80.5M | $10.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $69.4M | $37.0M |
| Total Assets | $112.9M | $57.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $80.5M | $10.7M | ||
| Q3 25 | $176.2M | $13.6M | ||
| Q2 25 | $28.2M | $12.5M | ||
| Q1 25 | $18.9M | $11.4M | ||
| Q4 24 | $8.2M | $15.7M | ||
| Q3 24 | $7.2M | $12.3M | ||
| Q2 24 | $12.1M | $11.9M | ||
| Q1 24 | $7.1M | $6.6M |
| Q4 25 | $69.4M | $37.0M | ||
| Q3 25 | $210.2M | $37.0M | ||
| Q2 25 | $88.6M | $30.4M | ||
| Q1 25 | $42.4M | $31.5M | ||
| Q4 24 | $39.9M | $32.6M | ||
| Q3 24 | $38.3M | $29.1M | ||
| Q2 24 | $42.4M | $23.5M | ||
| Q1 24 | $47.7M | $20.6M |
| Q4 25 | $112.9M | $57.1M | ||
| Q3 25 | $223.4M | $57.5M | ||
| Q2 25 | $109.3M | $52.6M | ||
| Q1 25 | $52.3M | $54.0M | ||
| Q4 24 | $47.1M | $59.2M | ||
| Q3 24 | $43.4M | $57.1M | ||
| Q2 24 | $49.1M | $53.0M | ||
| Q1 24 | $52.2M | $50.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $22.7M | $2.3M |
| Free Cash FlowOCF − Capex | — | $2.2M |
| FCF MarginFCF / Revenue | — | 12.0% |
| Capex IntensityCapex / Revenue | — | 0.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $22.7M | $2.3M | ||
| Q3 25 | $-4.9M | $-1.3M | ||
| Q2 25 | $-353.0K | $1.8M | ||
| Q1 25 | $1.2M | $-3.5M | ||
| Q4 24 | $-16.7M | $865.0K | ||
| Q3 24 | $-4.7M | $4.3M | ||
| Q2 24 | $1.4M | $1.4M | ||
| Q1 24 | $-8.6M | $-2.4M |
| Q4 25 | — | $2.2M | ||
| Q3 25 | — | $-1.5M | ||
| Q2 25 | — | $1.7M | ||
| Q1 25 | — | $-3.5M | ||
| Q4 24 | — | $470.0K | ||
| Q3 24 | — | $4.1M | ||
| Q2 24 | — | $1.2M | ||
| Q1 24 | — | $-2.5M |
| Q4 25 | — | 12.0% | ||
| Q3 25 | — | -9.6% | ||
| Q2 25 | — | 10.5% | ||
| Q1 25 | — | -18.8% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 14.4% | ||
| Q2 24 | — | 4.5% | ||
| Q1 24 | — | -11.1% |
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | 1.4% | ||
| Q2 25 | — | 1.0% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | — | 1.1% | ||
| Q1 24 | — | 0.6% |
| Q4 25 | — | — | ||
| Q3 25 | -0.04× | — | ||
| Q2 25 | -0.02× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -15.65× | — | ||
| Q3 24 | — | 2.57× | ||
| Q2 24 | — | 4.20× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DOMH
| Chief Operating Decision Maker | $30.1M | 100% |
| Commissions | $458.0K | 2% |
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
